Evaluation of a mobile app for cardiac patient follow-up
Official title: Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients
Run by University Hospital, Antwerp · NCT05951088 · Data updated 2026-11-12
This study tests a mobile app to see if it helps people with atrial fibrillation and heart failure manage their health better at home.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University Hospital, Antwerp Academic / other |
| Locations | 1 site (Edegem, Antwerp) |
| Status | Recruiting |
| Started | May 23, 2023 |
| Main results expected | May 30, 2026 |
| Study ends | May 30, 2026 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT05951088 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with atrial fibrillation or heart failure who can provide informed consent.
✕Probably not a fit
Patients who cannot read or speak Dutch, have severe cognitive impairments, or do not own a smartphone or tablet may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates a mobile application designed to support patients with atrial fibrillation and heart failure in managing their conditions at home. The app provides educational resources, allows users to track health metrics, manage medications, and assess their quality of life through questionnaires. The study focuses on assessing the app's usability, long-term adherence, and patient satisfaction over time. By leveraging technology, the trial aims to enhance patient engagement and improve health outcomes.
Why it matters
Potential benefit: If successful, this app could significantly improve the management and quality of life for patients with atrial fibrillation and heart failure.
How similar studies have gone: Other studies have shown promise in using mobile health applications for chronic disease management, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years, 2. Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records, 3. Patients who are capable of signing the informed consent. Exclusion Criteria: 1. Not able to speak and read Dutch, 2. Cognitive impaired (e.g. severe dementia), 3. No smartphone or tablet available.
Where it's running
-
University Hospital Antwerp
Edegem, Antwerp, Belgium Recruiting
Study contacts
- Principal investigator: Hein Heidbuchel — University Hospital, Antwerp
- Study coordinator: Lieselotte Knaepen
- Email: lieselotte.knaepen@uhasselt.be
- Phone: 003238213947
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital follow-up after thoracic surgery
This trial tests whether a digital follow-up program for adults discharged home after thoracic surgery can improve pain control and quality of life during the first 28 days after surgery compared with standard care.
-
Tele-diabetes remote monitoring for kids with type 1 diabetes
This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.
-
WhatsApp-based person-centered self-care support for homebound older adults
This project will test whether six bi-weekly WhatsApp video calls with nurse case managers using a person-centered approach help homebound older adults improve self-care, independence, and well-being compared with conventional provider-led calls.
-
Using ultrasound to improve diagnosis and management of carpal tunnel syndrome
This study is testing if using ultrasound can help doctors diagnose and manage carpal tunnel syndrome better than the usual nerve tests.
-
Mobile health platform for managing medications and drug labeling
This study tests if a new mobile app for managing medications can help adults who take multiple drugs stick to their treatment plans better than using paper methods.
-
Text messaging program to engage first-time fathers during pregnancy
This study tests a text messaging program designed to help first-time dads stay involved during pregnancy and after the baby is born by sending them helpful information and resources.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.